
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1069 | 1069 | 1118 | 771 | 1116 | 1465 |
Fund Return | 6.87% | 6.87% | 11.75% | -8.29% | 2.23% | 3.89% |
Place in category | 100 | 100 | 43 | 48 | 11 | 3 |
% in Category | 38 | 38 | 17 | 31 | 17 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Galaxy Innovation Growth Stock | 16.25B | 2.86 | 1.65 | 10.92 | ||
Galaxy CSI 300 Value Index Fund | 2.57B | -1.80 | 6.14 | 5.31 | ||
Galaxy ZhiLian Theme Flexible All | 962.46M | -4.27 | 4.89 | - | ||
Galaxy Yintai Financing Dividend | 951.61M | 2.39 | -5.88 | 2.25 | ||
Galaxy Industry Selected Stock | 794.61M | -1.17 | -6.30 | 0.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBCCS QY Medical Eq | 10.6B | 6.04 | -9.55 | - | ||
CMF CNI Bio Health Index | 9.81B | 0.43 | -20.62 | - | ||
Hwabao WP CSI Medical Index | 6.3B | 2.89 | -14.65 | - | ||
GF YiLiao BaoJian Eq A | 6.01B | 7.42 | -13.39 | - | ||
ICBCCS MedicalHlth Care Sect Secs I | 2.64B | 8.25 | -8.77 | 5.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jianmin Pharm | CNE000001HB7 | 8.14 | 46.67 | +1.70% | |
Jiangsu Hualan New Pharmaceutical Material | CNE100004YH2 | 7.45 | 25.88 | +0.35% | |
Yantai Dongcheng Pharma | CNE100001DP5 | 6.39 | 15.00 | +5.19% | |
INKON Life Technology | CNE100000XF6 | 6.06 | 9.30 | +0.65% | |
Zhejiang Huahai Pharm | CNE000001DL5 | 6.04 | 14.14 | -1.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review